Search details
1.
Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation.
J Virol
; 91(19)2017 10 01.
Article
in English
| MEDLINE | ID: mdl-28747495
2.
Simian T Lymphotropic Virus 1 Infection of Papio anubis: tax Sequence Heterogeneity and T Cell Recognition.
J Virol
; 91(20)2017 10 15.
Article
in English
| MEDLINE | ID: mdl-28724769
3.
DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
J Virol
; 89(8): 4158-69, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25631080
4.
Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.
J Virol
; 88(3): 1492-501, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24227853
5.
Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines.
Retrovirology
; 8: 39, 2011 May 18.
Article
in English
| MEDLINE | ID: mdl-21592361
6.
Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity.
Mol Ther Methods Clin Dev
; 20: 204-217, 2021 Mar 12.
Article
in English
| MEDLINE | ID: mdl-33426147
7.
A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy.
Vaccine
; 38(27): 4336-4345, 2020 06 02.
Article
in English
| MEDLINE | ID: mdl-32387010
8.
HEK293T cell lines defective for O-linked glycosylation.
PLoS One
; 12(6): e0179949, 2017.
Article
in English
| MEDLINE | ID: mdl-28654657
9.
Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion.
PLoS One
; 12(9): e0184915, 2017.
Article
in English
| MEDLINE | ID: mdl-28910387
10.
Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors.
PLoS One
; 11(2): e0148929, 2016.
Article
in English
| MEDLINE | ID: mdl-26849062
11.
A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model.
Vaccine
; 33(38): 4798-806, 2015 Sep 11.
Article
in English
| MEDLINE | ID: mdl-26241951
12.
HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity.
PLoS One
; 9(2): e90100, 2014.
Article
in English
| MEDLINE | ID: mdl-24587225
13.
Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.
Immunol Res
; 57(1-3): 303-10, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24198065
14.
Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.
Vaccine
; 30(4): 691-702, 2012 Jan 17.
Article
in English
| MEDLINE | ID: mdl-22146759
15.
EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.
J Leukoc Biol
; 90(2): 389-98, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21586676
16.
Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
Vaccine
; 29(11): 2110-9, 2011 Mar 03.
Article
in English
| MEDLINE | ID: mdl-21241732
Results
1 -
16
de 16
1
Next >
>>